2015 was a milestone year for genomic medicine. Spurred by new CPT reimbursement codes in the US and massive government sponsored sequencing initiatives across the globe such as President Obama’s Precision Medicine Initiative, the multi-billion dollar genome-guided, precision medicine industry took a giant leap forward this past year. Here at Tute Genomics we are thrilled … Continue reading Tute Genomics Delivers Big in the Year of Genome-Guided, Precision Medicine
Author: Josh Forsythe
Tute Genomics and Genatak Partner to Make Big Data Genomics Accessible to Clinical Labs Throughout Middle East
PROVO, Utah and JABRIYA, Kuwait, September 17, 2015 – Tute Genomics, a leader in clinical sequencing informatics and genomic interpretation technology, today announced a commercial partnership with Genatak, a leading center for genomic medicine in the Middle East. Genatak recently deployed Tute Genomics’ cloud-based platform to advance and scale the center’s genetic diagnostic service, and … Continue reading Tute Genomics and Genatak Partner to Make Big Data Genomics Accessible to Clinical Labs Throughout Middle East
In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part III
This is Part 3 in a three-part series on choosing the right informatics provider within the context of regulated clinical sequencing. You can read Part 1 here and Part 2 here. Tute Genomics. Playing with a full deck. “If you are a small place, wait for (i) the platforms, informatics, and reporting to be worked out, … Continue reading In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part III
In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part II
This is Part 2 in a three-part series on choosing the right informatics provider within the context of regulated clinical sequencing. You can read Part 1 here. It’s Not Build vs. Buy. Rather, Whom Do I Partner With? “It is important to be adequately capitalized when you start [genomic testing]. Trying to build NGS in … Continue reading In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part II
Democratizing Regulated Clinical Sequencing: Managing NGS Informatics Challenges with the Tute Genomics Platform
In this webinar recording, Dr. Bryce Daines, VP of Products at Tute Genomics, demonstrates how the Tute Genomics platform, in conjunction with partnering technologies, addresses NGS informatics challenges for clinical genomics. Download Slides — Webinar Abstract As the clinical utility of next-generation sequencing is increasingly proven, strategic opportunities abound for commercial diagnostic laboratories and health systems … Continue reading Democratizing Regulated Clinical Sequencing: Managing NGS Informatics Challenges with the Tute Genomics Platform
In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part I
“It is a lot easier to generate the data than [to] interpret it. You have to adequately resource the informatics function for interpretation. If you don’t, you end up with a very expensive paper weight in your department.” Genetics in Medicine, December 2014 Making a decision on how to resource informatics for your genomics operation … Continue reading In Regulated Clinical Sequencing, Choosing the Right Informatics Provider Trumps Everything. Part I
UCLA Next Generation Sequencing and Data Analysis Workshop
Registration is now open for UCLA’s Next Generation Sequencing and Data Analysis Workshop hosted by the Clinical Microarray Core (CMC) in conjunction with the Clinical and Translational Science Institute (CTSI), the Broad Stem Cell Research Center (BSCRC), and the Department of Pathology & Laboratory Medicine at UCLA. Tute Genomics is proud to participate in this year’s event. … Continue reading UCLA Next Generation Sequencing and Data Analysis Workshop
The Leah Story: Using exome sequencing to end the diagnostic odyssey for rare & undiagnosed diseases
On Wednesday, June 17th at 12:00pm ET Dr. Reid Robison, CEO of Tute Genomics delivered our inaugural Virtual Grand Rounds in Pediatric Genomic Medicine, a bi-monthly Tute Genomics webinar series where leading medical professionals will continue to present pediatric cases recently solved using next-generation sequencing technologies. ABSTRACT Significant cost reductions and rapid advancements in next-generation sequencing (NGS) … Continue reading The Leah Story: Using exome sequencing to end the diagnostic odyssey for rare & undiagnosed diseases
No Child Left Undiagnosed
“We envision a world where every child and every patient who requires a diagnosis receives one, in time for it to make a difference.” Reid Robison, MD CEO of Tute Genomics LAYING THE FOUNDATION FOR PRECISION MEDICINE “The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will … Continue reading No Child Left Undiagnosed